Institutional rails for biotech are lagging, but @BioProtocol flips that with milestone-gated Ignition Sales that lock funds to proofs, not promises $50K Researcher Sprints turn hypotheses into onchain DAOs without VC gatekeeping.
Quick receipts: Oct monthly report shows $275K fees from AUBRAI alone feeding SENS lab trials; 125M $BIO staked in 3 months means real TVL backing permissionless pools.
Livestream Nov 06 unpacks the flow: IP-token setup, AI co-pilots for branding, global buyer access via Base.
Stress-test for researchers:
❯ Map your sprint: $50K $250K cap fits de-risked pilots escrow releases on Gitcoin-style milestones.
❯ Check BioXP: yap about ecosystem tokens for emissions, multiply Ignition access.
Net: DeSci moves at software speed when funding proofs onchain. Track the sprint apps early movers fund longevity hacks before Q1 multi-chain.
#DeSci
332
5
The content on this page is provided by third parties. Unless otherwise stated, OKX is not the author of the cited article(s) and does not claim any copyright in the materials. The content is provided for informational purposes only and does not represent the views of OKX. It is not intended to be an endorsement of any kind and should not be considered investment advice or a solicitation to buy or sell digital assets. To the extent generative AI is utilized to provide summaries or other information, such AI generated content may be inaccurate or inconsistent. Please read the linked article for more details and information. OKX is not responsible for content hosted on third party sites. Digital asset holdings, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition.

